Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

AIM ImmunoTech Inventory Turnover Ratio 2010-2023 | AIM

AIM ImmunoTech inventory turnover ratio from 2010 to 2023. Inventory turnover ratio can be defined as a ratio showing how many times a company's inventory is sold and replaced over a period.
  
AIM ImmunoTech Inventory Turnover Ratio Historical Data
Date
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.021B $0.000B
AIM ImmunoTech Inc. is an immuno-pharma company. It is focused on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency diseases. The company's flagship products include Ampligen(R), Rintamod(R) and Alferon N Injection(R) which are in clinical stage. AIM ImmunoTech Inc., formerly known as Hemispherx Biopharma Inc., is based in Ocala, Florida.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $75.722B 30.79
Chugai Pharmaceutical (CHGCY) Japan $54.827B 24.51
Takeda Pharmaceutical (TAK) Japan $42.282B 6.85
Merck (MKGAF) Germany $21.034B 19.85
Astellas Pharma (ALPMY) Japan $18.212B 28.75
Sandoz Group AG (SDZNY) Switzerland $14.757B 0.00
Neurocrine Biosciences (NBIX) United States $14.261B 39.04
Shionogi (SGIOY) Japan $14.151B 12.69
United Therapeutics (UTHR) United States $11.555B 12.32
Catalent (CTLT) United States $10.202B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.721B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.925B 7.61
Revolution Medicines (RVMD) United States $6.658B 0.00
Ionis Pharmaceuticals (IONS) United States $6.162B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Madrigal Pharmaceuticals (MDGL) United States $5.014B 0.00
Orion OYJ (ORINY) Finland $4.940B 20.83
Alpine Immune Sciences (ALPN) United States $4.235B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.662B 0.00
Summit Therapeutics (SMMT) United States $3.138B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.117B 0.00
PTC Therapeutics (PTCT) United States $2.528B 0.00
Indivior (INDV) United States $2.503B 11.86
Corcept Therapeutics (CORT) United States $2.496B 22.61
Dyne Therapeutics (DYN) United States $2.294B 0.00
Ardelyx (ARDX) United States $2.141B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.098B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.042B 11.67
NewAmsterdam Pharma (NAMS) Netherlands $1.951B 0.00
Evotec AG (EVO) Germany $1.843B 0.00
Fusion Pharmaceuticals (FUSN) Canada $1.818B 0.00
Catalyst Pharmaceuticals (CPRX) United States $1.769B 18.28
Avadel Pharmaceuticals (AVDL) Ireland $1.687B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.597B 27.95
Soleno Therapeutics (SLNO) United States $1.535B 0.00
Xencor (XNCR) United States $1.499B 0.00
4D Molecular Therapeutics (FDMT) United States $1.369B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.269B 11.93
Pacira BioSciences (PCRX) United States $1.233B 12.27
Collegium Pharmaceutical (COLL) United States $1.211B 7.45
BioCryst Pharmaceuticals (BCRX) United States $1.087B 0.00
Enliven Therapeutics (ELVN) United States $1.077B 0.00
Cronos Group (CRON) Canada $1.012B 0.00
Relay Therapeutics (RLAY) United States $0.937B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.932B 0.00
Cassava Sciences (SAVA) United States $0.931B 0.00
ARS Pharmaceuticals (SPRY) United States $0.916B 0.00
Ocular Therapeutix (OCUL) United States $0.897B 0.00
USANA Health Sciences (USNA) United States $0.857B 13.90
Sage Therapeutics (SAGE) United States $0.797B 0.00
Siga Technologies (SIGA) United States $0.739B 10.94
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.736B 0.00
Savara (SVRA) United States $0.684B 0.00
Silence Therapeutics (SLN) United Kingdom $0.655B 0.00
Lyell Immunopharma (LYEL) United States $0.648B 0.00
Exscientia (EXAI) United Kingdom $0.604B 0.00
Calliditas Therapeutics AB (CALT) Sweden $0.600B 0.00
OmniAb (OABI) United States $0.552B 0.00
Verve Therapeutics (VERV) United States $0.538B 0.00
Larimar Therapeutics (LRMR) United States $0.526B 0.00
Altimmune (ALT) United States $0.522B 0.00
ProKidney (PROK) United States $0.514B 0.00
KalVista Pharmaceuticals (KALV) United States $0.512B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.466B 0.00
Korro Bio (KRRO) United States $0.453B 0.00
Lexeo Therapeutics (LXEO) United States $0.435B 0.00
Heron Therapeutics (HRTX) United States $0.428B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.408B 0.00
Esperion Therapeutics (ESPR) United States $0.402B 0.00
Tourmaline Bio (TRML) United States $0.398B 0.00
Black Diamond Therapeutics (BDTX) United States $0.388B 0.00
Harrow (HROW) United States $0.371B 0.00
Nature's Sunshine Products (NATR) United States $0.359B 20.10
Aquestive Therapeutics (AQST) United States $0.319B 0.00
Bioventus (BVS) United States $0.317B 0.00
Organogenesis (ORGO) United States $0.315B 59.75
Akebia Therapeutics (AKBA) United States $0.312B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.310B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.309B 0.00
ESSA Pharma (EPIX) Canada $0.309B 0.00
Fractyl Health (GUTS) United States $0.304B 0.00
Nektar Therapeutics (NKTR) United States $0.303B 0.00
Nanobiotix S.A (NBTX) France $0.298B 0.00
Xeris Biopharma Holdings (XERS) United States $0.281B 0.00
Pyxis Oncology (PYXS) United States $0.254B 0.00
Adherex Technologies (FENC) United States $0.248B 0.00
Foghorn Therapeutics (FHTX) United States $0.248B 0.00
Aldeyra Therapeutics (ALDX) United States $0.245B 0.00
Metagenomi (MGX) United States $0.242B 0.00
Eliem Therapeutics (ELYM) United States $0.240B 0.00
Avita Medical (RCEL) United States $0.230B 0.00
Conduit Pharmaceuticals (CDT) United States $0.227B 0.00
Zevra Therapeutics (ZVRA) United States $0.224B 0.00
Galectin Therapeutics (GALT) United States $0.215B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.214B 0.00
Century Therapeutics (IPSC) United States $0.205B 0.00
Acrivon Therapeutics (ACRV) United States $0.200B 0.00
Profound Medical (PROF) Canada $0.181B 0.00
MediWound (MDWD) Israel $0.179B 0.00
Telomir Pharmaceuticals (TELO) United States $0.179B 0.00
Innate Pharma SA (IPHYF) France $0.171B 0.00
Prelude Therapeutics (PRLD) United States $0.161B 0.00
Regulus Therapeutics (RGLS) United States $0.159B 0.00
Achieve Life Sciences (ACHV) Canada $0.157B 0.00
Elite Pharmaceuticals (ELTP) United States $0.153B 14.35
CytoDyn (CYDY) United States $0.150B 0.00
Incannex Healthcare (IXHL) Australia $0.147B 0.00
Cardiol Therapeutics (CRDL) Canada $0.138B 0.00
VAXART, INC (VXRT) United States $0.135B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.135B 2.84
Karyopharm Therapeutics (KPTI) United States $0.134B 0.00
OptiNose (OPTN) United States $0.129B 0.00
Inotiv (NOTV) United States $0.123B 0.00
Relmada Therapeutics (RLMD) United States $0.116B 0.00
Assertio Holdings (ASRT) United States $0.116B 5.30
FibroGen (FGEN) United States $0.115B 0.00
Citius Pharmaceuticals (CTXR) United States $0.111B 0.00
PMV Pharmaceuticals (PMVP) United States $0.108B 0.00
Vivani Medical (VANI) United States $0.098B 0.00
ProPhase Labs (PRPH) United States $0.096B 0.00
Aclaris Therapeutics (ACRS) United States $0.093B 0.00
AlloVir (ALVR) United States $0.093B 0.00
Jaguar Animal Health (JAGX) United States $0.088B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Tempest Therapeutics (TPST) United States $0.083B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.082B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.081B 0.00
Journey Medical (DERM) United States $0.071B 0.00
Champions Oncology (CSBR) United States $0.067B 0.00
Carisma Therapeutics (CARM) United States $0.066B 0.00
SCYNEXIS (SCYX) United States $0.065B 0.97
Mural Oncology (MURA) Ireland $0.064B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.058B 0.00
BioLineRx (BLRX) Israel $0.057B 0.00
Gain Therapeutics (GANX) United States $0.051B 0.00
Unicycive Therapeutics (UNCY) United States $0.044B 0.00
ElectroCore (ECOR) United States $0.042B 0.00
Rafael Holdings (RFL) United States $0.039B 0.00
Natural Alternatives (NAII) United States $0.038B 0.00
VYNE Therapeutics (VYNE) United States $0.038B 0.00
DURECT (DRRX) United States $0.037B 0.00
JanOne (JAN) United States $0.037B 0.00
CASI Pharmaceuticals (CASI) China $0.037B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.037B 0.00
Protara Therapeutics (TARA) United States $0.033B 0.00
Surrozen (SRZN) United States $0.033B 0.00
NRx Pharmaceuticals (NRXP) United States $0.032B 0.00
Lyra Therapeutics (LYRA) United States $0.032B 0.00
Viracta Therapeutics (VIRX) United States $0.031B 0.00
Enlivex Therapeutics (ENLV) Israel $0.029B 0.00
Oncternal Therapeutics (ONCT) United States $0.027B 0.00
Nutriband (NTRB) United States $0.027B 0.00
Iterum Therapeutics (ITRM) Ireland $0.026B 0.00
Lipocine (LPCN) United States $0.026B 0.00
PolyPid (PYPD) Israel $0.024B 0.00
TherapeuticsMD (TXMD) United States $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.022B 10.20
MEI Pharma (MEIP) United States $0.021B 1.08
Alaunos Therapeutics (TCRT) United States $0.021B 0.00
GlycoMimetics (GLYC) United States $0.020B 0.00
CERo Therapeutics Holdings (CERO) United States $0.020B 0.00
Aptorum Group (APM) United Kingdom $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
Nuvilex (PMCB) United States $0.018B 0.00
Talphera (TLPH) United States $0.018B 0.00
Indaptus Therapeutics (INDP) United States $0.017B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.016B 0.00
Minerva Neurosciences (NERV) United States $0.016B 0.00
Traws Pharma (TRAW) United States $0.016B 0.00
Mannatech (MTEX) United States $0.015B 0.00
Avalo Therapeutics (AVTX) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.013B 0.00
Dominari Holdings (DOMH) United States $0.013B 0.00
Cosmos Health (COSM) Greece $0.011B 0.00
Molecular Templates (MTEM) United States $0.011B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Plus Therapeutics (PSTV) United States $0.009B 0.00
Inhibikase Therapeutics (IKT) United States $0.008B 0.00
Universe Pharmaceuticals INC (UPC) China $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Heatwurx (PCSA) United States $0.007B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.007B 0.00
Ainos (AIMD) United States $0.007B 0.00
Mangoceuticals (MGRX) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
SHINECO (SISI) China $0.005B 0.00
TransCode Therapeutics (RNAZ) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.005B 0.00
Phio Pharmaceuticals (PHIO) United States $0.004B 0.00
Finch Therapeutics (FNCH) United States $0.004B 0.00
Acutus Medical (AFIB) United States $0.003B 0.00
Clever Leaves Holdings (CLVR) Canada $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.002B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
Bio-Path Holdings (BPTH) United States $0.002B 0.00
PainReform (PRFX) Israel $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Context Therapeutics (CNTX) United States $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.40
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 43.02